BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

10 articles for AJ Woodhead

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Recent developments in fragment-based drug discovery.EBI
Astex Therapeutics
Fragment-to-Lead Medicinal Chemistry Publications in 2022.EBI
Astex Pharmaceuticals
Fragment-based drug discovery applied to Hsp90. Discovery of two lead series with high ligand efficiency.EBI
Astex Therapeutics
Heterocyclic compounds for the inhibition of PASKBDB
Bioenergenix
Inhibitors of lysine specific demethylase-1BDB
Celgene Quanticel Research
Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes.BDB
Aventis Pharma
Lead optimization of 7-benzyloxy 2-(4'-pyridylmethyl)thio isoflavone aromatase inhibitors.BDB
Ohio State University